GlassScriptPhysician profile
Felicia Walker
NPI 1578956603
$2,569.45
in general payments reported to CMS, 2019-2025
9 companies · $54.19 in 2025
The $54.19 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $981 · 2022: $532 · 2023: $373 · 2024: $630 · 2025: $54.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,056.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,209.24 | 2021-2024 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $388.00 | 2021-2025 | |
| Novo Nordisk INC | $322.28 | 2021-2023 | |
| Lilly USA, LLC | $201.71 | 2023-2024 | Mounjaro |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2021 | |
| Urovant Sciences INC | $112.89 | 2021 | |
| Axsome Therapeutics, INC. | $100.94 | 2024 | Auvelity |
| Janssen Pharmaceuticals, INC | $97.22 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felicia Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.